Association of Apolipoprotein A5 Gene   −1131T>C Polymorphism with the Risk of Metabolic Syndrome in Korean Subjects. (30th December 2012)

• Record Type: Journal Article
• Authors: Song, Kwang Hoon; Cha, Seongwon; Yu, Sung-Gon; Yu, Hyunjoo; Oh, Soo A.; Kang, Nam-Sik
• Other Names: Kamboh M. Ilyas Academic Editor.
• Is Part Of: BioMed research international. Volume 2013(2013)
• Publication Date: 2012-12-30
• Subjects: Medicine -- Periodicals; Biology -- Periodicals; Biotechnology -- Periodicals; Life sciences -- Periodicals; 610.5
• DOI: 10.1155/2013/585134
• Languages: English
• ISSNs: 2314-6133

Abstract

Abstract : We assessed the associations between the APOA5 − 1131T> C polymorphism and lipid parameters and other risk factors of the metabolic syndrome in Korean subjects. A total of 2, 901 participants from 20 oriental medical hospitals in Korea were enrolled between 2006 and 2011. According to the modified National Cholesterol Education Program Adult Treatment Panel III definitions, subjects were classified into the metabolic syndrome group and control group. The APOA5 − 1131T> C genotype was significantly associated with serum high-density lipoprotein cholesterol levels (effect = − 1.700 mg/dL, P=6.550 -E07) in the total study population after adjustment for differences in age and gender. The association of the APOA5 − 1131T> C genotype with serum log-transformed triglyceride was also significant in an additive genetic model (effect = 0.056 mg/dL, P=2.286 E-19). After adjustment for age and gender, we determined that the odds ratio for the occurrence of the metabolic syndrome was 1.322 for C-allele carriers in the additive model (95% CI = [1.165 − 1.501], P=1.48 E-05). In the current study, we demonstrated that the APOA5 − 1131T> C polymorphism is associated with the metabolic syndrome because of its remarkable effect on serum triglyceride levels in Korean subjects.